Study: Adult-Use Cannabis Regulators Outpace Alcohol Agencies on Public Health Goals

Researchers reviewed the most recent annual reports from 22 cannabis agencies and 20 alcohol regulators, looking for how often they mentioned public health goals, collaboration with health agencies, prevention efforts, and work with law enforcement. They found that 68% of cannabis regulators explicitly mentioned public health in their mission or goals, compared to just 35% of alcohol agencies. Their findings were published by the International Journal of Drug Policy. Cannabis agencies were also more likely to describe public health-oriented activity. About 36% reported collaboration with public health agencies to collect data on cannabis-related outcomes, compared to 15% of alcohol regulators. Nearly half of cannabis regulators (46%) described running or supporting public health efforts such as education, outreach, or prevention programs, while 30% of alcohol agencies did the same.

Both sectors leaned heavily on law enforcement partnerships, and those efforts were more common than collaborations with health departments. Roughly two-thirds of cannabis regulators (64%) and 70% of alcohol regulators reported working with law enforcement, most often on driving under the influence, illicit markets, and license violations involving sales to minors.

The study also found clear differences based on how states legalized. In states that legalized adult-use cannabis through their legislatures rather than through ballot initiatives, cannabis regulators were more likely to articulate public health goals (88% versus 57%), report collaboration on health data (50% versus 29%), and describe public health efforts. Alcohol regulators in legislative-legalization states also tended to reference public health more often than their counterparts in ballot-measure states.

The authors note that there is still wide variation between states and that many cannabis agencies do not yet report systematic collaboration with public health departments. They say future work should examine whether regulatory agencies that track and report on health outcomes actually deliver better results for people who use cannabis and their communities.